BN Business News
Add your company to Business Communicator →

Business · 08/11/2023

FDA Announces Availability of Final Guidance for Real-Time Oncology Review

The FDA is releasing a final guidance for industry on Real-Time Oncology Review (RTOR), providing recommendations for submitting new drug and biologics applications with oncology indications for expedited review.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights